Made Hyderabad Proud By Manufacturing Covaxin To End Pandemic !!
Bharat Biotech is the Hyderabad based Biotech company that manufactured the covaxin vaccine. Bharat Biotech International Limited (BBIL), a leading biotech player in the globe having its headquarters in Hyderabad. The company has developed numerous vaccines that are exported to many countries. And, the most notable of these vaccines is Covaxin, which was launched to combat the Covid-19 pandemic. This article will succinctly speak about some major aspects pertaining to Bharat Biotech and Covaxin.
Hyderabad, the capital of Telangana State, is fast becoming the hub of the worldwide biotechnology sector. Several global leaders in this industry have opened their Indian facilities/offices in this city. The fact that more than 30 percent of the vaccines used in the world are manufactured in Hyderabad substantiates the above points.
- The manufacturing facility of BBIL is located at Genome Valley, which is a suburb of the city of Hyderabad. Bharat Biotech has branches in many countries, and the workforce of the company exceeds 1000.
- When the whole country and the world were being devastated by the crisis resulting from the Covid-19 pandemic, Bharat Biotech came to the rescue. This company was able to bring out the much-needed vaccine in the form of Covaxin in record time.
- To achieve that objective, Bharat Biotech collaborated with the University of Wisconsin-Madison and FluGen, a company headquartered in the United States. This initiative of Bharat Biotech underlines the significance of collaborations between private and public entities, especially when it is the question of handling a major crisis.
- Covaxin, a completely native vaccine of India, is composed of coronaviruses that have already perished. On a global basis, Covaxin is recognized as one of the most effective of all the Covid-19 vaccines. It displays an effectiveness of well over 90 percent when it comes to preventing the severe form of COVID-19. Likewise, the vaccine offers a protection of around 75 percent for keeping mild-to-moderate COVID-19 at bay.
- Bharat Biotech has exported Covaxin to different regions of the world, and that too, when the pandemic severity was at its peak. All those efforts and the impressive success rate of Covaxin turned out to be helpful. The reputation of the biotech industry of Hyderabad was immensely boosted.
- Bharat Biotech has been the pioneer in developing vaccines for Zika and Chikungunya. The biotech company makes vaccines related to Japanese Encephalitis. The laboratories of Bharat Biotech pertain to the BSL (biosafety level) 3 category, and this underscores the company’s commitment to safety.
- During the initial phase of the COVID-19 vaccination drive, some sources expressed doubts over the efficacy of Covaxin. Consequently, many people were reluctant to take this vaccine. But after that, due to the endeavors of Bharat Biotech, all these doubts were dispelled.
- More and more details were conveyed to the public about the scientific findings validating the vaccine’s effectiveness. This greatly helped in wider acceptance of Covaxin; people themselves started witnessing the level of protection provided by this vaccine.
- In response to the questions raised against Covaxin in the early stages, many prominent international agencies carried out extensive research on this vaccine. The research concluded that this vaccine is appropriate to be given to any individual who is above the age of 18. Barring rare instances, Covaxin does not cause any grave reactions, and it gives good levels of protection against life-threatening Covid symptoms.
- Do watch the movie “Vaccine War” to understand the value addition made by Indian scientists and the challenges they faced, especially all the staff of NIV and ICMR.